Toxic Leukoencephalopathy following Fludarabine-Associated Hematopoietic Cell Transplantation
Open Access
- 1 March 2011
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 17 (3), 300-308
- https://doi.org/10.1016/j.bbmt.2010.04.003
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Acute Toxic Leukoencephalopathy: Potential for Reversibility Clinically and on MRI With Diffusion-Weighted and FLAIR ImagingAmerican Journal of Roentgenology, 2009
- Neurologic Complications in Children After Hemaopoietic Stem Cell Transplantation: A Single-Center ExperienceTransplantation Proceedings, 2007
- Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, and Clinical SignificanceTransplantation and Cellular Therapy, 2007
- Posterior Reversible Encephalopathy Syndrome: Incidence of Atypical Regions of Involvement and Imaging FindingsAmerican Journal of Roentgenology, 2007
- Cancer therapy-associated CNS neuropathology: an update and review of the literatureActa Neuropathologica, 2006
- Chemotherapy-induced toxic leukoencephalopathy causes a wide range of symptoms: a series of four autopsiesLaboratory Investigation, 2004
- Prospective evaluation of neurological complications after allogeneic bone marrow transplantationNeurology, 2003
- Neurological complications after stem cell transplantation in childhoodBone Marrow Transplantation, 1999
- Neurotoxicity of purine analogs: a review.Journal of Clinical Oncology, 1994
- Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity.Journal of Clinical Oncology, 1986